Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DONSON is required for CMG helicase assembly in the mammalian cell cycle. | EMBO Rep | 2023 | 37781960 | PubTator, text mining | PubMed |
| Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR. | Dis Model Mech | 2023 | 37772705 | PubTator, text mining | PubMed |
| Long Noncoding RNA ZBED5-AS1 Facilitates Tumor Progression and Metastasis in Lung Adenocarcinoma via ZNF146/ATR/Chk1 Axis. | Int J Mol Sci | 2023 | 37762228 | PubTator, text mining | PubMed |
| TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas. | Biomolecules | 2023 | 37759698 | PubTator, text mining | PubMed |
| CD44-SNA1 integrated cytopathology for delineation of high grade dysplastic and neoplastic oral lesions. | PLoS One | 2023 | 37747904 | PubTator, text mining | PubMed |
| Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers. | ScientificWorldJournal | 2023 | 37746664 | PubTator, text mining | PubMed |
| YAP1 affects the prognosis through the regulation of stemness in endometrial cancer. | PeerJ | 2023 | 37744228 | PubTator, text mining | PubMed |
| Characterization of histone chaperone MCM2 as a key regulator in arsenic-induced depletion of H3.3 at genomic loci. | Toxicol Appl Pharmacol | 2023 | 37734572 | PubTator, text mining | PubMed |
| The cell-cycle choreography of H3 variants shapes the genome. | Mol Cell | 2023 | 37734377 | PubTator, text mining | PubMed |
| Synergism between CMG helicase and leading strand DNA polymerase at replication fork. | Nat Commun | 2023 | 37730685 | PubTator, text mining | PubMed |
| Pan cancer characterization of genes whose expression has been associated with LINE-1 antisense promoter activity. | Mob DNA | 2023 | 37723560 | PubTator, text mining | PubMed |
| Determinants of response to CDK4/6 inhibitors in the real-world setting. | NPJ Precis Oncol | 2023 | 37704753 | PubTator, text mining | PubMed |
| Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients. | Front Immunol | 2023 | 37701444 | PubTator, text mining | PubMed |
| Establishing Functional Retina in a Dish: Progress and Promises of Induced Pluripotent Stem Cell-Based Retinal Neuron Differentiation. | Int J Mol Sci | 2023 | 37686457 | PubTator, text mining | PubMed |
| Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer. | Int J Mol Sci | 2023 | 37685875 | PubTator, text mining | PubMed |
Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37682177 | PubTator, text mining | PubMed |
| Effective lung cancer control: An unaccomplished challenge in cancer research. | Cytojournal | 2023 | 37681073 | PubTator, text mining | PubMed |
| A new wave of innovations within the DNA damage response. | Signal Transduct Target Ther | 2023 | 37679326 | PubTator, text mining | PubMed |
| DPH1 and DPH2 variants that confer susceptibility to diphthamide deficiency syndrome in human cells and yeast models. | Dis Model Mech | 2023 | 37675463 | PubTator, text mining | PubMed |
| MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification. | Breast Cancer (Dove Med Press) | 2023 | 37674872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=13